Earnings NewsHealthcareBellicum Pharmaceuticals EPS of -$18.99Mar. 11, 2015 4:12 PM ETBellicum Pharmaceuticals, Inc. (BLCM)By: SA News Team Bellicum Pharmaceuticals (NASDAQ:BLCM): Q4 EPS of -$18.99 may not be comparable to consensus of -$0.37. Revenue of $15K (-98.1% Y/Y). Press Release Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsJ&J CFO, pharma head reportedly in running to be next CEOMark Zuckerberg sells about $190M in stock as part of trading planDiehl Defence receives $650M missile contract from LatviaNasdaq, S&P, Dow fall as Wall Steet takes a breather after notching 2023 closing highU.S. strong buy ideas for the next 12 months – according to CitiSee More »About BLCMSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBLCM--Bellicum Pharmaceuticals, Inc.SLRX--Salarius Pharmaceuticals, Inc.ALLR--Allarity Therapeutics, Inc.PHIO--Phio Pharmaceuticals Corp.ZVSA--ZyVersa Therapeutics, Inc.CompareTrending AnalysisTrending News